Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
Year : 1996  |  Volume : 17  |  Issue : 1  |  Page : 8-22

Tumor markers in clinical oncology.


The Gujarat Cancer & Research Institute, Ahmedabad, India

Correspondence Address:
JM Bhatavdekar
The Gujarat Cancer & Research Institute, Ahmedabad, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

The association of biologic markers with cancer has been recognised for many decades. Tumor markers are substances that can be measured quantitatively by immunochemical or biochemical means in body fluids or tissues to detect a cancer and possibly the organ where it resides, to establish the exten of tumor burden before treatment, and to monitor the response to therapy. These include tumor associated antigens, specific proteins, metabolites, and oncogenes and oncogene products. The most commonly used tumor markersare:carcinoembryonic antigen(CEA), alpha feto-protein(AFP), human chorionic goandotrophin(beta HCG), prostate specific antigen(PSA) and CA 125.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed546    
    Printed57    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal